- $556.77m
- $726.38m
- $294.48m
- 75
- 61
- 49
- 65
Annual income statement for Cerence, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | R2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 303 | 331 | 387 | 328 | 294 |
| Cost of Revenue | |||||
| Gross Profit | 204 | 223 | 286 | 231 | 199 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 292 | 309 | 327 | 512 | 322 |
| Operating Profit | 10.9 | 22.4 | 60.6 | -184 | -27.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 11.2 | -23 | 48.3 | -199 | -36.4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 100 | -18.3 | 45.9 | -311 | -56.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 100 | -18.3 | 45.9 | -311 | -56.3 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 100 | -18.3 | 45.9 | -311 | -56.3 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 3.21 | -0.209 | 1.29 | -4.24 | -1.21 |